Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Apr 2025 08:52 AM
RNS
Holding(s) in Company
01 Apr 2025 07:00 AM
RNS
OXB Total Voting Rights
27 Mar 2025 04:45 PM
RNS
Director Declaration
03 Mar 2025 09:00 AM
RNS
Total Voting Rights
26 Feb 2025 07:00 AM
RNS
OXB to present at Leerink Conference
20 Feb 2025 03:42 PM
RNS
Holding(s) in Company
20 Feb 2025 01:32 PM
RNS
OXB Lentiviral Vectors Used in Gene Therapy Trial
20 Feb 2025 01:13 PM
RNS
Standard form for notification of major holdings
17 Feb 2025 07:00 AM
RNS
Full Year Trading Update and Notice of Results
05 Feb 2025 07:00 AM
RNS
Appointment of New Joint Corporate Broker
03 Feb 2025 07:00 AM
RNS
Total Voting Rights
23 Jan 2025 11:07 AM
RNS
Block Listing Application
16 Jan 2025 04:23 PM
RNS
Holding(s) in Company
16 Jan 2025 04:20 PM
RNS
Holding(s) in Company
15 Jan 2025 04:30 PM
RNS
Holding(s) in Company
02 Jan 2025 07:00 AM
RNS
Block Listing Return
02 Jan 2025 07:00 AM
RNS
Total Voting Rights
02 Dec 2024 07:00 AM
RNS
Total Voting Rights
22 Nov 2024 02:56 PM
RNS
Grant of options
18 Nov 2024 07:00 AM
RNS
Board Changes
15 Nov 2024 07:00 AM
RNS
OXB to present at Jefferies Healthcare Conference
05 Nov 2024 02:23 PM
RNS
Grant of options
04 Nov 2024 10:56 AM
RNS
Holding(s) in Company
01 Nov 2024 07:00 AM
RNS
Total Voting Rights
31 Oct 2024 07:00 AM
RNS
Holding(s) in Company
21 Oct 2024 09:47 AM
RNS
Block Listing Application
04 Oct 2024 03:25 PM
RNS
Grant of Options
03 Oct 2024 04:05 PM
RNS
Holding(s) in Company
01 Oct 2024 05:33 PM
RNS
Holding(s) in Company
01 Oct 2024 07:00 AM
RNS
Total Voting Rights
23 Sep 2024 07:00 AM
RNS
Interim Results
18 Sep 2024 07:00 AM
RNS
Oxford Biomedica rebrands as OXB
02 Sep 2024 07:00 AM
RNS
Lucinda Crabtree joins OXB as CFO today
02 Sep 2024 07:00 AM
RNS
Total Voting Rights
09 Aug 2024 11:01 AM
RNS
Director Declaration
08 Aug 2024 07:00 AM
RNS
Half Year Trading Update and Notice of Results
01 Aug 2024 07:00 AM
RNS
Total Voting Rights
30 Jul 2024 04:51 PM
RNS
Director Declaration
29 Jul 2024 04:31 PM
RNS
Director Declaration
29 Jul 2024 04:31 PM
RNS
Director Declaration
25 Jul 2024 07:00 AM
RNS
OXB Appoints Non-Executive Director
25 Jul 2024 07:00 AM
RNS
Block Listing Application
22 Jul 2024 07:00 AM
RNS
Holding(s) in Company
17 Jul 2024 07:00 AM
RNS
OXB announces CFO transition
03 Jul 2024 09:19 AM
RNS
Person Closely Associated Dealing
01 Jul 2024 11:24 AM
RNS
BLOCK LISTING RETURN
01 Jul 2024 07:00 AM
RNS
Total Voting Rights
28 Jun 2024 04:02 PM
RNS
Holding(s) in Company
27 Jun 2024 01:57 PM
RNS
Person Closely Associated Dealing
24 Jun 2024 05:44 PM
RNS
Result of Annual General Meeting

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings